Status:
COMPLETED
Randomized Trial: High Power Short Duration Versus Ablation Index
Lead Sponsor:
Robert Bosch Medical Center
Conditions:
Atrial Fibrillation Paroxysmal
Catheter Ablation
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The single procedure success rates of durable pulmonary vein isolation (PVI) for paroxysmal atrial fibrillation (PAF) varies between 80 and 90 %. This prospective, randomized study investigated the e...
Detailed Description
A total number of 176 patients undergoing de-novo catheter ablation for paroxysmal AF are planned to be randomized to two different treatment arms. In group-A patients, PVI was performed with RF-energ...
Eligibility Criteria
Inclusion
- Paroxysmal atrial fibrillation
- written informed consent
Exclusion
- inability to obtain written informed consent
- persistent atrial fibrillation
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2023
Estimated Enrollment :
176 Patients enrolled
Trial Details
Trial ID
NCT05251545
Start Date
September 1 2021
End Date
September 1 2023
Last Update
August 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Robert Bosch Medical Center
Stuttgart, Germany, 70376